Evidence Synthesis
CTLLAB's 72.29% accelerated to its highest quarterly value, up from 4.98%, as the company demonstrated a significant improvement in its 4.98% and 6.1% year-over-year growth rates.
Evidence Synthesis
Last synthesized: 21 Oct 2026, 04:05
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
CTLLAB's 72.29% accelerated to its highest quarterly value, up from 4.98%, as the company demonstrated a significant improvement in its 4.98% and 6.1% year-over-year growth rates.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 72.29 % | 4.98 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 4.98 % | 4.4 | ▲ |
| REVENUE_GROWTH_YOY | 6.1 % | -26.8 | ▲ |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 1,200 shares | 171 | ▲ |
| CLOSE_PRICE | 32 INR | 32 | - |
Cite this
Source: Samhati evidence synthesis for CTLLAB (2026-10-21). Observation: CTLLAB's 72.29% accelerated to its highest quarterly value, up from 4.98%, as the company demonstrated a significant improvement in its 4.98% and 6.1% year-over-year growth rates. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/ctllab
Filing step-changes